Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Ion channel macromolecular complexes in cardiomyocytes: roles in sudden cardiac death.

Abriel H, Rougier JS, Jalife J.

Circ Res. 2015 Jun 5;116(12):1971-88. doi: 10.1161/CIRCRESAHA.116.305017. Review.

2.

SAP97 and cortactin remodeling in arrhythmogenic Purkinje cells.

Dun W, Wright P, Danilo P Jr, Mohler PJ, Boyden PA.

PLoS One. 2014 Sep 3;9(9):e106830. doi: 10.1371/journal.pone.0106830. eCollection 2014.

3.

CaMKII regulation of cardiac K channels.

Mustroph J, Maier LS, Wagner S.

Front Pharmacol. 2014 Feb 21;5:20. doi: 10.3389/fphar.2014.00020. eCollection 2014. Review.

4.

Role for myosin-V motor proteins in the selective delivery of Kv channel isoforms to the membrane surface of cardiac myocytes.

Schumacher-Bass SM, Vesely ED, Zhang L, Ryland KE, McEwen DP, Chan PJ, Frasier CR, McIntyre JC, Shaw RM, Martens JR.

Circ Res. 2014 Mar 14;114(6):982-92. doi: 10.1161/CIRCRESAHA.114.302711. Epub 2014 Feb 7.

5.

Kv1.5 in the immune system: the good, the bad, or the ugly?

Felipe A, Soler C, Comes N.

Front Physiol. 2010 Nov 16;1:152. doi: 10.3389/fphys.2010.00152. eCollection 2010.

6.

Emerging concepts in the pharmacogenomics of arrhythmias: ion channel trafficking.

Harkcom WT, Abbott GW.

Expert Rev Cardiovasc Ther. 2010 Aug;8(8):1161-73. doi: 10.1586/erc.10.89. Review.

7.

Ion channel trafficking: a new therapeutic horizon for atrial fibrillation.

Schumacher SM, Martens JR.

Heart Rhythm. 2010 Sep;7(9):1309-15. doi: 10.1016/j.hrthm.2010.02.017. Epub 2010 Feb 13. Review.

8.

Tetramerization domain mutations in KCNA5 affect channel kinetics and cause abnormal trafficking patterns.

Burg ED, Platoshyn O, Tsigelny IF, Lozano-Ruiz B, Rana BK, Yuan JX.

Am J Physiol Cell Physiol. 2010 Mar;298(3):C496-509. doi: 10.1152/ajpcell.00464.2009. Epub 2009 Dec 16.

9.

Cholesterol modulates the recruitment of Kv1.5 channels from Rab11-associated recycling endosome in native atrial myocytes.

Balse E, El-Haou S, Dillanian G, Dauphin A, Eldstrom J, Fedida D, Coulombe A, Hatem SN.

Proc Natl Acad Sci U S A. 2009 Aug 25;106(34):14681-6. doi: 10.1073/pnas.0902809106. Epub 2009 Aug 17.

10.

Kif5b is an essential forward trafficking motor for the Kv1.5 cardiac potassium channel.

Zadeh AD, Cheng Y, Xu H, Wong N, Wang Z, Goonasekara C, Steele DF, Fedida D.

J Physiol. 2009 Oct 1;587(Pt 19):4565-74. doi: 10.1113/jphysiol.2009.178442. Epub 2009 Aug 12.

11.

Inhibitory actions of the phosphatidylinositol 3-kinase inhibitor LY294002 on the human Kv1.5 channel.

Wu J, Ding WG, Matsuura H, Tsuji K, Zang WJ, Horie M.

Br J Pharmacol. 2009 Jan;156(2):377-87. doi: 10.1111/j.1476-5381.2008.00017.x. Epub 2009 Jan 16.

12.

Mechanisms of cardiac potassium channel trafficking.

Steele DF, Eldstrom J, Fedida D.

J Physiol. 2007 Jul 1;582(Pt 1):17-26. Epub 2007 Apr 5. Review.

Supplemental Content

Support Center